Cited by 73Cardiovascular Function and Risk FactorsGenetics, Aging, and Longevity in Model OrganismsCardiovascular Disease and Adiposity

Obesity accelerates cardiovascular ageing

Open access
Ruperez, Celia, Madeo, Frank, de Cabo, Rafael, Kroemer, Guido, Abdellatif, Mahmoud·2025·European Heart Journal

Abstract

A global obesity pandemic, coupled with an increasingly ageing population, is exacerbating the burden of cardiovascular disease. Indeed, clinical and experimental evidence underscores a potential connection between obesity and ageing in the pathogenesis of various cardiovascular disorders. This is further supported by the notion that weight reduction not only effectively reduces major cardiovascular events in elderly individuals but is also considered the gold standard for lifespan extension, in obese and non-obese model organisms. This review evaluates the intricate interplay between obesity and ageing from molecular mechanisms to whole organ function within the cardiovascular system. By comparatively analysing their characteristic features, shared molecular and cell biological signatures between obesity and ageing are unveiled, with the intent to shed light on how obesity accelerates cardiovascular ageing. This review also elaborates on how emerging metabolic interventions targeting obesity might protect from cardiovascular diseases largely through antagonizing key molecular mechanisms of the ageing process itself. In sum, this review aims to provide valuable insight into how understanding these interconnected processes could guide the development of novel and effective cardiovascular therapeutics for a growing aged population with a concerning obesity problem.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehaf216

Cites

295 of 295 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obesity substantially increases the risk of diabetes, cardiovascular disease, fatty liver disease, and certain cancers.

    “Obesity substantially increases the risk of diabetes, cardiovascular disease, fatty liver disease, and certain cancers, while imposing enormous societal and economic burdens.[2][3][4]”

    From The Triple‐Agonist Revolution: Retatrutide and the Paradigm Shift in Multi‐Hormonal Pharmacotherapy for Obesity and Cardiometabolic Comorbidities (2026) · cites this paper as [3]

    The Introduction links obesity to increased cardiovascular risk, and the Figure 5 caption in the concluding remarks lists type 2 diabetes among conditions associated with obesity. The passages in our copy do not establish the claimed increased risk of fatty liver disease or certain cancers. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ruperez, C., Madeo, F., de Cabo, R., Kroemer, G., & Abdellatif, M.
Affiliations
  • Department of Cardiology, Medical University of Graz , Auenbruggerplatz 15, Graz 8036 ,
  • University of Graz (AT)
  • Translational Gerontology Branch, National Institute on Aging , Baltimore, MD ,
  • Inserm (FR)
Corresponding author
  • Kroemer, Guido
  • Abdellatif, Mahmoud
Venue
European Heart Journal
Published
2025-04-08
Volume
46
Issue
23
Pages
2161-2185
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W4409261750
Cited by
73
References
295
Citations by year
2026: 53 · 2025: 20
FWCI
13.24
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc)
Funders
  • Medical University of Graz
  • BioTechMed-Graz
  • Austrian Science Fund
  • European Commission
  • FWF
  • ANR
  • Agence National de la Recherche (ANR-22-CE14-0066, ANR-23-CE44-0030, ANR-23-R4HC-0006)
  • Association pour la recherche sur le cancer
  • Cancéropôle Ile-de-France
  • Fondation pour la Recherche Médicale
  • European Joint Programme on Rare Diseases
  • European Research Council Advanced Investigator Award (101052444)
  • European Union Horizon 2020 research and innovation programmes Oncobiome (825410)
  • Prevalung (101095604)
  • Neutrocure (861878)
  • Hevolution Network on Senescence in Aging
  • Institut National du Cancer
  • Institut Universitaire de France
  • Mark Foundation
  • PAIR-Obésité INCa_1873
  • LUCA-pi (ANR-21-RHUS-0017, ANR-23-RHUS-0010)
  • Seerave Foundation
  • SIRIC Cancer Research and Personalized Medicine
  • Ministère des Solidarités et de la Santé
  • INSERM
  • University of Graz
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
obesity, cardiovascular aging, cardiovascular disease, weight loss, lifespan extension, metabolic intervention, cardiovascular therapeutics, older adults
MeSH terms
Aging, Animals, Cardiovascular Diseases, Humans, Obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review